학술논문
Phlegmasia Cerulea Dolens Secondary to COVID-19 and May-Thurner Syndrome: A Case Report.
Document Type
Report
Author
Alghamdi L; Internal Medicine, King Fahad Medical City, Riyadh, SAU.; Alattab N; Vascular Surgery, King Fahad Medical City, Riyadh, SAU.; Alwohaibi A; Internal Medicine, King Fahad Medical City, Riyadh, SAU.; Alotaibi YH; Internal Medicine, King Fahad Medical City, Riyadh, SAU.; AlSheef M; Internal Medicine, King Fahad Medical City, Riyadh, SAU.
Source
Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
Subject
Language
English
ISSN
2168-8184
Abstract
Coronavirus disease 2019 (COVID-19) is associated with significant thromboembolic risk. Extensive deep vein thrombosis can infrequently progress to phlegmasia cerulea dolens that carries high morbidity and mortality rates. We report a case of a middle-aged male presenting with phlegmasia cerulea dolens in the context of COVID-19 and underlying May-Thurner syndrome, associated with transiently positive antiphospholipid antibodies.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright © 2022, Alghamdi et al.)
Competing Interests: The authors have declared that no competing interests exist.
(Copyright © 2022, Alghamdi et al.)